By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login

ECO Animal Health Group plc (EAH.L)

LSE Currency in GBP
£79.00
+£5.00
+6.76%
Last Update: 18 Jul 2025, 12:46
£53.53M
Market Cap
0.00
P/E Ratio (TTM)
Forward Dividend Yield
£50.00 - £126.00
52 Week Range

EAH.L Stock Price Chart

Explore ECO Animal Health Group plc interactive price chart. Choose custom timeframes to analyze EAH.L price movements and trends.

There is nothing to show.

EAH.L Company Profile

Discover essential business fundamentals and corporate details for ECO Animal Health Group plc (EAH.L) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

26 Sept 1995

Employees

227.00

CEO

David Charles Hallas

Description

ECO Animal Health Group plc, together with its subsidiaries, develops, registers, and markets pharmaceutical products for animals worldwide. The company provides Aivlosin, a macrolide antibiotic for the treatment of enteric and respiratory diseases in pigs and poultry. It also offers generic drugs, such as Ecomectin, Ecoheart, Ecotraz, and Ecomintic, which are endectocides and other antiparasitics for the treatment and prevention of parasites, such as worms, ticks, and lices in cattle, sheep, pigs, horses, and dogs; and Chlortetracycline and Oxytetracycline for treatment of bacterial infections in pigs, poultry, and cattle. ECO Animal Health Group plc was founded in 1972 and is headquartered in New Malden, the United Kingdom.

EAH.L Financial Timeline

Browse a chronological timeline of ECO Animal Health Group plc corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 26 Nov 2025

Earnings released on 14 Jul 2025

Earnings released on 25 Nov 2024

EPS came in at -£0.03, while revenue for the quarter reached £33.18M, missing expectations by -0.05%.

Earnings released on 15 Jul 2024

EPS came in at £0.03, while revenue for the quarter reached £51.41M.

Earnings released on 21 Mar 2024

EPS came in at -£0.02, while revenue for the quarter reached £38.01M, beating expectations by +0.02%.

Earnings released on 10 Jul 2023

EPS came in at -£0.00, while revenue for the quarter reached £50.45M, beating expectations by +1.31%.

Earnings released on 23 Nov 2022

EPS came in at £0.02, while revenue for the quarter reached £34.86M.

Earnings released on 31 Mar 2022

EPS came in at -£0.01, while revenue for the quarter reached £43.72M.

Earnings released on 30 Sept 2021

EPS came in at -£0.00, while revenue for the quarter reached £38.47M.

Dividend declared on 23 Sept 2021

A dividend of £0.74 per share was announced, adjusted to £0.74. The dividend was paid on 22 Oct 2021.

Earnings released on 31 Mar 2021

EPS came in at £0.09, while revenue for the quarter reached £63.08M.

Earnings released on 30 Sept 2020

EPS came in at £0.03, while revenue for the quarter reached £42.53M.

EAH.L Stock Performance

Access detailed EAH.L performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

There is nothing to show.
EAH.L
Company Name
Exchange
Market Currency
Report Currency
Price
Price Change
Percentage Change
50-Day Average Price
200-Day Average Price
Trading Volume
Market Capitalization
EAH.L
2025
2024
2023
2022
2021
Revenue
Gross Profit
Earnings Before Interest and Taxes (EBIT)
Net Income
Total Current Assets
Total Assets
Total Liabilities
Net Debt
Total Equity
Cash Flow from Operating
Cash Flow from Investing
Cash Flow from Financing
Free Cash Flow

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More